Providence Cancer Center researchers score promising results with experimental cancer treatment

In a trial using human patients, Providence Cancer Center researchers reported using an antibody called OX40 to activate the immune system against a variety of invading cancers: melanoma, kidney, pancreatic and colon cancers.

http://www.oregonlive.com/health/index.ssf/2013/11/researchers_in_portland_score.html